BridgeBio Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Sep 24 | Sell€134,698,765 | KKR & Co. Inc. | Company | 5,800,000 | €23.22 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 628,929 | 0.334% |
Individual Insiders | 10,124,525 | 5.38% |
Hedge Funds | 25,120,991 | 13.4% |
VC/PE Firms | 25,260,971 | 13.4% |
Institutions | 126,897,322 | 67.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
25,260,971 | €621.4m | -18.7% | 3.62% | |||
25,120,991 | €618.0m | 0% | 2.33% | |||
14,054,748 | €345.7m | 6.3% | 0.01% | |||
12,878,839 | €316.8m | 3.46% | 0.01% | |||
6,905,851 | €169.9m | 0% | no data | |||
6,068,125 | €149.3m | 0% | 59.65% | |||
5,854,140 | €144.0m | 8.55% | 0.01% | |||
4,388,873 | €108.0m | -15.2% | 3.55% | |||
4,312,531 | €106.1m | 30.2% | 0.05% | |||
3,632,604 | €89.4m | 6.35% | 3.56% | |||
3,290,409 | €80.9m | 14.9% | 0.01% | |||
2,804,394 | €69.0m | 0% | 0.21% | |||
2,648,957 | €65.2m | -9.67% | 0.05% | |||
2,452,404 | €60.3m | -13.8% | 0.02% | |||
2,212,085 | €54.4m | 0% | no data | |||
2,156,449 | €53.0m | 144% | 0.05% | |||
1,860,364 | €45.8m | 0% | 0.24% | |||
1,858,351 | €45.7m | -42% | 2.12% | |||
1,854,863 | €45.6m | 59.3% | 1.02% | |||
1,798,441 | €44.2m | 3.27% | no data | |||
1,681,701 | €41.4m | -1.71% | 2.54% | |||
1,646,202 | €40.5m | 44.5% | 0.07% | |||
1,548,488 | €38.1m | 25.4% | 0.02% | |||
1,539,835 | €37.9m | -33.8% | no data | |||
1,534,972 | €37.8m | 40.5% | 0.03% |